NEW BRUNSWICK, N.J. (AP) — Health care giant Johnson & Johnson said Monday that it expects to take a charge of about $100 million to its first-quarter net income due to Venezuela's currency devaluation.
Johnson & Johnson, the world's biggest seller of health care products, said the decision is based on its preliminary assessment of the impact of the Venezuelan government's move, which took effect Feb. 13. The charge amounts to 4 cents per share.
The maker of prescription medicines, medical devices and consumer health products such as Tylenol said the charge is not related to remeasurement of its local balance sheet on that date.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
